Related Experiment Videos
Simple bone cyst: etiology, classification, pathology, and treatment modalities
1Department of Pediatric Orthopaedics, Dana Children's Hospital, Tel-Aviv Medical Center, Israel.
Journal of Pediatric Orthopedics. Part B
|November 12, 1998
Summary
Simple bone cysts (SBCs) are mysterious bone lesions in children, often causing fractures. Their unpredictable behavior and high recurrence rates necessitate a review of various treatment options.
Area of Science:
- Orthopedic Surgery
- Pediatric Radiology
- Pathology
Background:
- Simple bone cysts (SBCs) are enigmatic, asymptomatic bone lesions primarily affecting children.
- The etiology of SBCs remains unknown, contributing to their unpredictable biological behavior and clinical course.
- These lesions frequently lead to pathological fractures, posing a significant clinical challenge.
Purpose of the Study:
- To discuss the clinical, radiological, and biological features of simple bone cysts.
- To provide a comparative review of various treatment modalities for SBCs.
- To highlight the latest advancements in SBC treatment, including percutaneous autologous marrow grafting.
Main Methods:
- Review of clinical presentations and radiological findings of simple bone cysts.
- Pathological analysis of SBCs to understand their biological characteristics.
- Comparative analysis of treatment outcomes for resection, curettage, bone grafting, steroid injection, and percutaneous autologous marrow grafting.
Main Results:
- Simple bone cysts exhibit unpredictable behavior and high recurrence rates across different anatomical sites.
- Various treatment options exist, each with associated recurrence rates.
- Percutaneous autologous marrow grafting shows promise as a newer treatment approach.
Conclusions:
- Simple bone cysts present diagnostic and therapeutic challenges due to their unknown etiology and unpredictable nature.
- Effective management requires a thorough understanding of the lesion's features and a careful selection of treatment.
- Further research into novel treatments like percutaneous autologous marrow grafting is warranted to improve outcomes and reduce recurrence.